Sensation Disorders clinical trials at UCSF

1 research study open to eligible people

Sensation disorders impact how individuals experience sight, sound, or touch. UCSF is testing treatments that might improve vision for those with Leber Congenital Amaurosis Type 10. These studies use placebos to compare the effectiveness of the drugs being examined.

Showing trials for

  • Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

    open to eligible people ages 6 years and up

    The purpose of this double-masked, randomized, placebo-controlled, paired-eye study is to evaluate the efficacy, safety and tolerability of Sepofarsen in subjects with Leber Congenital Amaurosis (LCA) due to the c.2991+1655A>G (p.Cys998X) mutation in the CEP290.

    San Francisco, California and other locations

Last updated: